These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34684666)

  • 21. Obesity contributes to telomere shortening in polycystic ovary syndrome.
    Kogure GS; Verruma CG; Santana BA; Calado RT; Ferriani RA; Furtado CLM; Dos Reis RM
    Reprod Sci; 2024 Jun; 31(6):1601-1609. PubMed ID: 38393627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Single Arm Pilot Study of Effects of Berberine on the Menstrual Pattern, Ovulation Rate, Hormonal and Metabolic Profiles in Anovulatory Chinese Women with Polycystic Ovary Syndrome.
    Li L; Li C; Pan P; Chen X; Wu X; Ng EH; Yang D
    PLoS One; 2015; 10(12):e0144072. PubMed ID: 26645811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eight-hour time-restricted feeding improves endocrine and metabolic profiles in women with anovulatory polycystic ovary syndrome.
    Li C; Xing C; Zhang J; Zhao H; Shi W; He B
    J Transl Med; 2021 Apr; 19(1):148. PubMed ID: 33849562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome.
    Javed Z; Papageorgiou M; Deshmukh H; Kilpatrick ES; Mann V; Corless L; Abouda G; Rigby AS; Atkin SL; Sathyapalan T
    Nutrients; 2019 Jan; 11(1):. PubMed ID: 30658483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
    Barber TM; Wass JA; McCarthy MI; Franks S
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF; Li X; Zhu MW
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment.
    Ciaraldi TP; Aroda V; Mudaliar SR; Henry RR
    Metabolism; 2013 Nov; 62(11):1587-96. PubMed ID: 23958241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index.
    Samy N; Hashim M; Sayed M; Said M
    Dis Markers; 2009; 26(4):163-70. PubMed ID: 19729797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pioglitazone can improve liver sex hormone-binding globulin levels and lipid metabolism in polycystic ovary syndrome by regulating hepatocyte nuclear factor-4α.
    Zhao H; Wang D; Xing C; Lv B; Wang X; He B
    J Steroid Biochem Mol Biol; 2023 May; 229():106265. PubMed ID: 36737028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.
    Kurek Eken M; Sahin Ersoy G; Yayla Abide C; Sanverdi İ; Devranoglu B; Kutlu T; Çevik Ö
    J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.
    Yilmaz SA; Kerimoglu OS; Pekin AT; Incesu F; Dogan NU; Celik C; Unlu A
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the Efficacy of Sex Hormone-Binding Globulin in Insulin Resistance Assessment Based on HOMA-IR in Patients with PCOS.
    Chen F; Liao Y; Chen M; Yin H; Chen G; Huang Q; Chen L; Yang X; Zhang W; Wang P; Yin G
    Reprod Sci; 2021 Sep; 28(9):2504-2513. PubMed ID: 33721297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study on the Effect of Berberine, Myoinositol, and Metformin in Women with Polycystic Ovary Syndrome: A Prospective Randomised Study.
    Mishra N; Verma R; Jadaun P
    Cureus; 2022 Jan; 14(1):e21781. PubMed ID: 35251851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Relationship between Vitamin D Metabolites and Androgens in Women with Polycystic Ovary Syndrome.
    Mesinovic J; Teede HJ; Shorakae S; Lambert GW; Lambert EA; Naderpoor N; de Courten B
    Nutrients; 2020 Apr; 12(5):. PubMed ID: 32357490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovarian SAHA syndrome is associated with a more insulin-resistant profile and represents an independent risk factor for glucose abnormalities in women with polycystic ovary syndrome: a prospective controlled study.
    Dalamaga M; Papadavid E; Basios G; Vaggopoulos V; Rigopoulos D; Kassanos D; Trakakis E
    J Am Acad Dermatol; 2013 Dec; 69(6):922-30. PubMed ID: 24120563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated circulating levels of betatrophin are associated with polycystic ovary syndrome.
    Calan M; Yilmaz O; Kume T; Unal Kocabas G; Yesil Senses P; Senses YM; Temur M; Gursoy Calan O
    Endocrine; 2016 Jul; 53(1):271-9. PubMed ID: 26832343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect and mechanism of berberine against polycystic ovary syndrome.
    Zhang SW; Zhou J; Gober HJ; Leung WT; Wang L
    Biomed Pharmacother; 2021 Jun; 138():111468. PubMed ID: 33740526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of a ketogenic diet in overweight women with polycystic ovary syndrome.
    Paoli A; Mancin L; Giacona MC; Bianco A; Caprio M
    J Transl Med; 2020 Feb; 18(1):104. PubMed ID: 32103756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation analysis of myonectin levels with metabolic and hormonal disorders in patients with polycystic ovary syndrome.
    Zhang J; Chen L; Ye J
    Ann Palliat Med; 2021 Mar; 10(3):3404-3409. PubMed ID: 33752430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.